Northern Trust Corp Burning Rock Biotech LTD Transaction History

Northern Trust Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.75 - $10.44 $28,000 - $167,040	16,000 New	16,000 $46,000
Q4 2021 Feb 08, 2022	SELL	$9.43 - $17.14 $684,712 - $1.24 Million	-72,610 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$17.37 - $27.92 $450,108 - $723,490	-25,913 Reduced 26.3%	72,610 $1.3 Million
Q2 2021 Aug 13, 2021	BUY	$26.14 - $37.45 $2.58 Million - $3.69 Million	98,523 New	98,523 $2.9 Million

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $703M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.